Injectable Bioresponsive Gel Depot for Enhanced Immune Checkpoint Blockade
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Injectable Bioresponsive Gel Depot for Enhanced Immune Checkpoint Blockade
Authors
Keywords
-
Journal
ADVANCED MATERIALS
Volume -, Issue -, Pages 1801527
Publisher
Wiley
Online
2018-05-22
DOI
10.1002/adma.201801527
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy
- (2018) Chao Wang et al. Science Translational Medicine
- H2O2-responsive liposomal nanoprobe for photoacoustic inflammation imaging and tumor theranostics via in vivo chromogenic assay
- (2017) Qian Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy
- (2017) Chao Wang et al. Nature Biomedical Engineering
- Synergistic Transcutaneous Immunotherapy Enhances Antitumor Immune Responses through Delivery of Checkpoint Inhibitors
- (2016) Yanqi Ye et al. ACS Nano
- Esterase-Activated Charge-Reversal Polymer for Fibroblast-Exempt Cancer Gene Therapy
- (2016) Nasha Qiu et al. ADVANCED MATERIALS
- Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody
- (2016) Chao Wang et al. NANO LETTERS
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Thermosensitive Polypeptide Hydrogels as a Platform for ROS-Triggered Cargo Release with Innate Cytoprotective Ability under Oxidative Stress
- (2016) Qinghua Xu et al. Advanced Healthcare Materials
- Biodegradable stimuli-responsive polypeptide materials prepared by ring opening polymerization
- (2015) Yong Shen et al. CHEMICAL SOCIETY REVIEWS
- Norepinephrine-induced myeloid-derived suppressor cells block T-cell responsesviageneration of reactive oxygen species
- (2015) Yufeng Liu et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Programmed Death-1 Controls T Cell Survival by Regulating Oxidative Metabolism
- (2015) Victor Tkachev et al. JOURNAL OF IMMUNOLOGY
- A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy
- (2015) Samuel G. Awuah et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer
- (2015) Li-Ying OuYang et al. Journal of Translational Medicine
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- Therapeutic Potential and Challenges of Natural Killer Cells in Treatment of Solid Tumors
- (2015) Andrea Gras Navarro et al. Frontiers in Immunology
- Rational Design of Polyion Complex Nanoparticles to Overcome Cisplatin Resistance in Cancer Therapy
- (2013) Xian-Zhu Yang et al. ADVANCED MATERIALS
- Light-Responsive Helical Polypeptides Capable of Reducing Toxicity and Unpacking DNA: Toward Nonviral Gene Delivery
- (2013) Lichen Yin et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Enzyme-Triggered Cargo Release from Methionine Sulfoxide Containing Copolypeptide Vesicles
- (2013) April R. Rodriguez et al. BIOMACROMOLECULES
- Thermosensitive hydrogels based on polypeptides for localized and sustained delivery of anticancer drugs
- (2013) Yilong Cheng et al. BIOMATERIALS
- The expanding roles of 1-methyl-tryptophan (1-MT): in addition to inhibiting kynurenine production, 1-MT activates the synthesis of melatonin in skin cells
- (2013) Ana C. R. Moreno et al. FEBS Journal
- Deciphering and Reversing Tumor Immune Suppression
- (2013) Greg T. Motz et al. IMMUNITY
- Targeting immunosuppression for cancer therapy
- (2013) Cristina Ghirelli et al. JOURNAL OF CLINICAL INVESTIGATION
- Incorporation of d-alanine into poly(ethylene glycol) and l-poly(alanine-co-phenylalanine) block copolymers affects their nanoassemblies and enzymatic degradation
- (2013) Min Kyung Joo et al. Soft Matter
- Decisive Role of Hydrophobic Side Groups of Polypeptides in Thermosensitive Gelation
- (2012) Yilong Cheng et al. BIOMACROMOLECULES
- Glycopolypeptides with a Redox-Triggered Helix-to-Coil Transition
- (2012) Jessica R. Kramer et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Physiological Roles of Mitochondrial Reactive Oxygen Species
- (2012) Laura A. Sena et al. MOLECULAR CELL
- Tumor suppressor TSC1 is critical for T-cell anergy
- (2012) D.-L. Xie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammatory Mediators Hold the Key to Dendritic Cell Suppression and Tumor Progression
- (2011) K. C. Sheng et al. CURRENT MEDICINAL CHEMISTRY
- An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
- (2011) Christiane A. Opitz et al. NATURE
- Chemistry and biology of reactive oxygen species in signaling or stress responses
- (2011) Bryan C Dickinson et al. Nature Chemical Biology
- The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells
- (2011) Christiane A. Opitz et al. PLoS One
- Oxidative stress, inflammation, and cancer: How are they linked?
- (2010) Simone Reuter et al. FREE RADICAL BIOLOGY AND MEDICINE
- Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma
- (2009) Tomoko Inaba et al. GYNECOLOGIC ONCOLOGY
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now